share_log

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

坎托·菲茨杰拉德恢复对TherapeuticSMD的中立态度,宣布目标股价为5美元
Benzinga Real-time News ·  2023/01/11 06:47

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

Cantor Fitzgerald分析师Louise Chen恢复TreateuticsMD(纳斯达克:TXMD)的中性,并宣布5美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发